日本クレア株式会社 トップ > プロモーション情報 > Promotion (English) > For studying brain infarction in vivo with very high reproductive and survivability- C.B-17 Brain Infarction Model Mouse

For studying brain infarction in vivo with very high reproductive and survivability- C.B-17 Brain Infarction Model Mouse

  • LINEで送る
  • このエントリーをはてなブックマークに追加
For studying brain infarction in vivo with very high reproductive and survivability- C.B-17 Brain Infarction Model Mouse

Very high reproductive brain infarction animal models
Surgical FOX CHASE SCID C.B-17/Icr-scid/scidJcl and FOX CHASE SCID C.B-17/Icr-+/+Jcl.

- Background

There were basically 2 problems for traditional brain infarction models. 1) Low ischaemia place reproducibility between animals. 2) Cannot do the meaningful term study due to its low survivability. These two problems caused impossibilities for analyzing chronicity period convalescence of administrative agents and recovery of cerebral functions after a stroke.

This model was made by surgical treatment for better ischaemia place reproducibility and long life by Dr. Tomohiro Matsuyama, Hyogo College of medicine. (2019)

- Creation

By using improved Tamura method, MCA of SCID(FOX CHASE SCID C.B-17/Icr-scid/scidJcl) and C.B-17(FOX CHASE SCID C.B-17/Icr-+/+Jcl) are treated an electrocoagulation directly and deligation to be a brain infarction model.



- High reproducibility

This method makes a selective cortical infarction inducement with high reproducibility in SCID and C.B-17 by direct electrocoagulation and ligation at a middle cerebral artery (MCA) distance part.



- High long-term survival rate (180 days)

This model shows high long-term survival rate with high cortical infarction reproducibility to its chronic phase. (Maximum 180 days) The survival rate after brain infarction treatment is 100% (16/16) in 90 days and 94% (15/16) in 180 days.

- Characteristic

Due to the high reproducibility, this model can reduce the number of animals used for various test agent screening test. In addition, it is possible to conduct a treatment effect and side effect assessments at its chronicle phase due to the long term survival rate. (180 days) In this fact, this is useful as a local eternal ischemia animal model to imitate a partial human brain infarction. For using SCID mouse model, immunodeficiency animal, it is possible to conduct a treatment assessment with donor-cell hetero transplantation.

- Reference

Catalogue (Japanese only)


- Question / Inquiry / Order

Please contact us via website contact form for question / inquiry / order request.


If you want to confrim how to import CLEA Japan product, please click below
  • LINEで送る
  • このエントリーをはてなブックマークに追加

タグ

お問い合わせ

CONTACT

実験動物や関連の飼料、器材、受託業務に関するご質問やご相談を承ります。
どうぞ、お気軽にお問い合わせください。